Ven Viswanathan’s Post

🌿 Cannabis Rescheduling FAQ: What Now? 🌿 The DEA’s proposal to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) is a significant development, though the process is still ongoing and could face various challenges before finalization. While this move aligns with the Department of Health and Human Services’ (HHS) recommendations, it does not legalize cannabis federally. 🚀 Jonathan Havens, managing partner at Saul Ewing, emphasizes the importance of this potential change, highlighting it as the most significant federal reform since the CSA’s enactment. He notes that the rulemaking process is swift by Washington standards but still complex, with a public comment period and potential legal challenges expected. 💼 Rescheduling cannabis to Schedule III would alleviate some restrictions, notably removing the burdensome Internal Revenue Code Section 280E, allowing state-legal cannabis companies to take standard business tax deductions. However, it won’t fully integrate cannabis into the legal framework enjoyed by other industries like alcohol and tobacco. ⚖️ Legal experts like Sander Zagzebski caution that Schedule III reclassification won’t immediately normalize cannabis business operations. The industry would still face regulatory challenges, and banking legislation such as the SAFER Banking Act remains crucial. While rescheduling marks progress, comprehensive federal legalization and regulatory clarity are still needed. 📈 As a Cannabis Franchise Broker with Cannabis10X, I see this as a pivotal moment. We have numerous red-hot opportunities in the cannabis market. Reach out to me directly to capitalize on this rapidly growing sector and secure your investment in the future of cannabis. 🌱 #CannabisIndustry #CannabisInvestment #CannabisRescheduling #CannabisBusiness #CannabisReform Orginal art by: HaraLine Cannabis10X 5

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics